Valneva and Serum Institute of India Partner to Deliver Asia’s First Single-Shot Chikungunya Vaccine

  Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, and Serum Institute of India (SII), the world’s...

December 19, 2024 | Thursday | News
Redefining Precision Medicine: Demaris Mills on IDT’s Role in Precision Medicine and Gene Synthesis for 2025

In a thought-provoking Q&A with BioPharma BoardRoom, Demaris Mills, President of Integrated DNA Technologies (IDT), discusses the transformative advanc...

December 12, 2024 | Thursday | Interaction
Advancing Healthspan for All: Dr. Mehmood Khan Spotlights Aging Science Trends for 2025

  In an exclusive interview with BioPharma Boardroom, Dr. Mehmood Khan, Chief Executive Officer of Hevolution Foundation, shares insights into the tr...

December 12, 2024 | Thursday | News
MGI Tech and Universidad de San Martín de Porres Forge Alliance to Advance Genetic Research in Peru

MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, announced a partnership with...

December 02, 2024 | Monday | News
Agilent Drives Strategic Transformation with Strong FY2024 Results, CEO Padraig McDonnell Leads Restructuring for Market Agility and Growth

Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, has released its financial results for ...

November 26, 2024 | Tuesday | Company results
Merck CEO Belén Garijo Declares Strong Q3 2024 Growth, Reaffirms Path to Profitable 2024 Finish

Net sales up organically by 3.8% to € 5.3 billion EBITDA pre up organically by 16.9% to € 1.6 billion EBITDA ...

November 21, 2024 | Thursday | Company results
Quotient Sciences Installs World’s First GMP Biofoundry-in-a-Box for Accelerated RNA Manufacturing

" Quotient Sciences, in collaboration with Centillion, has installed the revolutionary Biofoundry-in-a-Box (BiaB™) at its Alnwick site, marking a n...

November 20, 2024 | Wednesday | News
Rona Therapeutics’ RN0191 Demonstrates Significant LDL-C Reduction in Phase 1 Trial

Rona Therapeutics, a leader in innovative RNA-based therapies, presented positive results from the Phase 1 clinical trial of RN0191 at the American Heart A...

November 18, 2024 | Monday | News
GenScript Biotech Global Forum 2024: Paving the Way for Innovation and Investment in Cell and Gene Therapy

- The global cell and gene therapy (CGT) industry is poised for remarkable growth, driven by significant advances in life sciences and robust investments...

November 14, 2024 | Thursday | News
Bio-Rad Advances Oncology Diagnostics with IVDR Certification for CML Assay and Strategic Collaborations in MRD and ctDNA Detection

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced updates on its onco...

November 13, 2024 | Wednesday | News
Perceptive eClinical Launches ClinPhone 5: An Innovative RTSM Platform to Transform Clinical Trials

Perceptive eClinical, part of Perceptive Group, is pleased to announce the launch of ClinPhone 5, a ground-breaking new Randomization and Trial Supply Mana...

November 12, 2024 | Tuesday | News
GenScript Biotech Expands with New Operations and Logistics Center in Sydney, Enhancing Support for Australian Biotech

GenScript Biotech Corporation ("GenScript"), a global leader in life sciences services and products, has announced the establishment of new operations site...

November 11, 2024 | Monday | News
European Medicines Agency Approves Dupixent for Treating Eosinophilic Esophagitis in Children Aged 1-11

The European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in children as young as one year of age. Specifical...

November 07, 2024 | Thursday | News
Headway Joins National Quality Forum's Aligned Innovation Initiative to Redefine Behavioral Health Quality Measures

Headway, the company building a new mental healthcare system, announced its participation in the Aligned Innovation initiative, a groundbreaking cross-indu...

November 06, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close